Cargando…

Optimal planning of the COVID-19 vaccine supply chain

This work presents a novel framework to simultaneously address the optimal planning of COVID-19 vaccine supply chains and the optimal planning of daily vaccinations in the available vaccination centres. A new mixed integer linear programming (MILP) model is developed to generate optimal decisions re...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgiadis, Georgios P., Georgiadis, Michael C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313510/
https://www.ncbi.nlm.nih.gov/pubmed/34373118
http://dx.doi.org/10.1016/j.vaccine.2021.07.068
_version_ 1783729364022591488
author Georgiadis, Georgios P.
Georgiadis, Michael C.
author_facet Georgiadis, Georgios P.
Georgiadis, Michael C.
author_sort Georgiadis, Georgios P.
collection PubMed
description This work presents a novel framework to simultaneously address the optimal planning of COVID-19 vaccine supply chains and the optimal planning of daily vaccinations in the available vaccination centres. A new mixed integer linear programming (MILP) model is developed to generate optimal decisions regarding the transferred quantities between locations, the inventory profiles of central hubs and vaccination centres and the daily vaccination plans in the vaccination centres of the supply chain network. Specific COVID-19 characteristics, such as special cold storage technologies, limited shelf-life of mRNA vaccines in refrigerated conditions and demanding vaccination targets under extreme time pressure, are aptly modelled. The goal of the model is the minimization of total costs, including storage and transportation costs, costs related to fleet and staff requirements, as well as, indirect costs imposed by wasted doses. A two-step decomposition strategy based on a divide-and-conquer and an aggregation approach is proposed for the solution of large-scale problems. The applicability and efficiency of the proposed optimization-based framework is illustrated on a study case that simulates the Greek nationwide vaccination program. Finally, a rolling horizon technique is employed to reactively deal with possible disturbances in the vaccination plans. The proposed mathematical framework facilitates the decision-making process in COVID-19 vaccine supply chains into minimizing the underlying costs and the number of doses lost. As a result, the efficiency of the distribution network is improved, thus assisting the mass vaccination campaigns against COVID-19.
format Online
Article
Text
id pubmed-8313510
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83135102021-07-27 Optimal planning of the COVID-19 vaccine supply chain Georgiadis, Georgios P. Georgiadis, Michael C. Vaccine Article This work presents a novel framework to simultaneously address the optimal planning of COVID-19 vaccine supply chains and the optimal planning of daily vaccinations in the available vaccination centres. A new mixed integer linear programming (MILP) model is developed to generate optimal decisions regarding the transferred quantities between locations, the inventory profiles of central hubs and vaccination centres and the daily vaccination plans in the vaccination centres of the supply chain network. Specific COVID-19 characteristics, such as special cold storage technologies, limited shelf-life of mRNA vaccines in refrigerated conditions and demanding vaccination targets under extreme time pressure, are aptly modelled. The goal of the model is the minimization of total costs, including storage and transportation costs, costs related to fleet and staff requirements, as well as, indirect costs imposed by wasted doses. A two-step decomposition strategy based on a divide-and-conquer and an aggregation approach is proposed for the solution of large-scale problems. The applicability and efficiency of the proposed optimization-based framework is illustrated on a study case that simulates the Greek nationwide vaccination program. Finally, a rolling horizon technique is employed to reactively deal with possible disturbances in the vaccination plans. The proposed mathematical framework facilitates the decision-making process in COVID-19 vaccine supply chains into minimizing the underlying costs and the number of doses lost. As a result, the efficiency of the distribution network is improved, thus assisting the mass vaccination campaigns against COVID-19. Elsevier Ltd. 2021-08-31 2021-07-27 /pmc/articles/PMC8313510/ /pubmed/34373118 http://dx.doi.org/10.1016/j.vaccine.2021.07.068 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Georgiadis, Georgios P.
Georgiadis, Michael C.
Optimal planning of the COVID-19 vaccine supply chain
title Optimal planning of the COVID-19 vaccine supply chain
title_full Optimal planning of the COVID-19 vaccine supply chain
title_fullStr Optimal planning of the COVID-19 vaccine supply chain
title_full_unstemmed Optimal planning of the COVID-19 vaccine supply chain
title_short Optimal planning of the COVID-19 vaccine supply chain
title_sort optimal planning of the covid-19 vaccine supply chain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313510/
https://www.ncbi.nlm.nih.gov/pubmed/34373118
http://dx.doi.org/10.1016/j.vaccine.2021.07.068
work_keys_str_mv AT georgiadisgeorgiosp optimalplanningofthecovid19vaccinesupplychain
AT georgiadismichaelc optimalplanningofthecovid19vaccinesupplychain